Mohammad Ali Haghighatpanah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad Ali Haghighatpanah has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Sadegh Mazaheri-Tehrani
Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran
4 shared publications - Maryam Heidarpour
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
3 shared publications - Bahar Darouei
Isfahan Cardiovascular Research Center, Cardiovascular Research Institute Isfahan University of Medical Sciences Isfahan Iran
2 shared publications - Davood Shafie
Heart Failure Research Center Cardiovascular Research Institute Isfahan University of Medical Sciences Isfahan Iran
2 shared publications - Mehrbod Vakhshoori
Division of Nephrology, Department of Medicine Loma Linda University Loma Linda California USA
2 shared publications - Reza Amani-Beni
Isfahan Cardiovascular Research Center, Cardiovascular Research Institute Isfahan University of Medical Sciences Isfahan Iran
2 shared publications
Latest Publications
- Open Access
- 26 May 2026
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 78 (1) , 39
The impact of left ventricular assist devices on kidney function: a systematic review and meta-analysis
Background: Kidney dysfunction is common in patients with advanced heart failure and is associated with adverse clinical outcomes. Left ventricular assist device (LVAD) implantation may influence renal function through hemodynamic and cardiorenal changes. We performed a meta-analysis to evaluate longitudinal changes in estimated glomerular filtration rate (eGFR) following LVAD implantation. Results: We systematically searched six databases for studies reporting eGFR before and after LVAD implantation until March 2026. The primary analysis used a multivariate random-effects meta-analysis to jointly pool repeated follow-up estimates while accounting for within-study dependence across time points. Pooled mean changes in eGFR and 95% confidence intervals (CIs) were estimated at 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months, 1 year, 2 years, and 3 years after implantation. A total of 38 studies contributing 95 effect sizes were included. Compared with baseline, pooled mean eGFR was significantly higher at 1 week (18.83 mL/min/1.73 m²; 95% CI: 13.21, 24.46), 2 weeks (18.29; 95% CI: 12.11, 24.48), 1 month (23.77; 95% CI, 19.48, 28.07), 3 months (15.20; 95% CI: 10.95, 19.46), 6 months (7.97; 95% CI: 3.72, 12.22), 9 months (8.27; 95% CI: 2.10, 14.44), and 1 year (7.34; 95% CI: 2.83, 11.85), but not at 2 or 3 years. In subgroup analyses, studies with baseline eGFR < 60 mL/min/1.73 m² showed significant increases across all evaluated follow-up intervals, whereas those with baseline eGFR ≥ 60 mL/min/1.73 m² showed significant increases only through 3 months. Conclusions: LVAD implantation was associated with higher eGFR during the early postoperative period, with the largest increase observed at 1 month. However, because most included studies were pre-post analyses without non-LVAD comparator groups, these findings should be interpreted cautiously and do not establish a causal effect. Future research should explore the long-term impact of LVAD on renal health to optimize care strategies and outcomes.
- 26 May 2026
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 78 (1) , 39
Open AccessThe impact of left ventricular assist devices on kidney function: a systematic review and meta-analysis
Background: Kidney dysfunction is common in patients with advanced heart failure and is associated with adverse clinical outcomes. Left ventricular assist device (LVAD) implantation may influence renal function through hemodynamic and cardiorenal changes. We performed a meta-analysis to evaluate longitudinal changes in estimated glomerular filtration rate (eGFR) following LVAD implantation. Results: We systematically searched six databases for studies reporting eGFR before and after LVAD implantation until March 2026. The primary analysis used a multivariate random-effects meta-analysis to jointly pool repeated follow-up estimates while accounting for within-study dependence across time points. Pooled mean changes in eGFR and 95% confidence intervals (CIs) were estimated at 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months, 1 year, 2 years, and 3 years after implantation. A total of 38 studies contributing 95 effect sizes were included. Compared with baseline, pooled mean eGFR was significantly higher at 1 week (18.83 mL/min/1.73 m²; 95% CI: 13.21, 24.46), 2 weeks (18.29; 95% CI: 12.11, 24.48), 1 month (23.77; 95% CI, 19.48, 28.07), 3 months (15.20; 95% CI: 10.95, 19.46), 6 months (7.97; 95% CI: 3.72, 12.22), 9 months (8.27; 95% CI: 2.10, 14.44), and 1 year (7.34; 95% CI: 2.83, 11.85), but not at 2 or 3 years. In subgroup analyses, studies with baseline eGFR < 60 mL/min/1.73 m² showed significant increases across all evaluated follow-up intervals, whereas those with baseline eGFR ≥ 60 mL/min/1.73 m² showed significant increases only through 3 months. Conclusions: LVAD implantation was associated with higher eGFR during the early postoperative period, with the largest increase observed at 1 month. However, because most included studies were pre-post analyses without non-LVAD comparator groups, these findings should be interpreted cautiously and do not establish a causal effect. Future research should explore the long-term impact of LVAD on renal health to optimize care strategies and outcomes.
- 5 January 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (4) , 2536-2550
Associations between anthropometric measures of obesity and prediabetes risk: A dose–response meta‐analysis of cohort studies
Obesity is a well‐established risk factor for diabetes; however, its association with prediabetes remains controversial. Here, we aimed to assess the association between obesity and prediabetes risk. A systematic literature review was conducted using PubMed, Web of Science, Embase, Scopus, and Ovid through 3 May 2025, using keyword searches. We included cohort studies that assessed the association between anthropometric indices, specifically body mass index (BMI), waist circumference (WC), and prediabetes risk, operationalised as the development of prediabetes during the longitudinal investigation. We performed multiple meta‐analyses assessing BMI and WC as continuous and categorical variables, including dose–response relationships with prediabetes risk. Of the 8434 records retrieved from the primary search, 28 were included in the meta‐analysis. Considering BMI as both a continuous and a categorical variable indicated significant associations with prediabetes risk (risk ratio [RR]: 1.10 (95% CI: 1.03, 1.17) and RR: 1.52 (95% CI: 1.19, 1.94), respectively). The dose–response analysis confirmed a linear association between a 1‐unit increase in BMI and a 4.6% increase in the risk of prediabetes. However, there was no significant association between WC and prediabetes risk either as a continuous or categorical variable. This study supports the use of BMI as a risk marker for prediabetes, whereas WC showed no significant association. While substantial heterogeneity and limited WC data warrant caution, the findings underscore the value of monitoring general obesity for early risk stratification and to prevent glycemic deterioration.
- 5 January 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (4) , 2536-2550
Associations between anthropometric measures of obesity and prediabetes risk: A dose–response meta‐analysis of cohort studies
Obesity is a well‐established risk factor for diabetes; however, its association with prediabetes remains controversial. Here, we aimed to assess the association between obesity and prediabetes risk. A systematic literature review was conducted using PubMed, Web of Science, Embase, Scopus, and Ovid through 3 May 2025, using keyword searches. We included cohort studies that assessed the association between anthropometric indices, specifically body mass index (BMI), waist circumference (WC), and prediabetes risk, operationalised as the development of prediabetes during the longitudinal investigation. We performed multiple meta‐analyses assessing BMI and WC as continuous and categorical variables, including dose–response relationships with prediabetes risk. Of the 8434 records retrieved from the primary search, 28 were included in the meta‐analysis. Considering BMI as both a continuous and a categorical variable indicated significant associations with prediabetes risk (risk ratio [RR]: 1.10 (95% CI: 1.03, 1.17) and RR: 1.52 (95% CI: 1.19, 1.94), respectively). The dose–response analysis confirmed a linear association between a 1‐unit increase in BMI and a 4.6% increase in the risk of prediabetes. However, there was no significant association between WC and prediabetes risk either as a continuous or categorical variable. This study supports the use of BMI as a risk marker for prediabetes, whereas WC showed no significant association. While substantial heterogeneity and limited WC data warrant caution, the findings underscore the value of monitoring general obesity for early risk stratification and to prevent glycemic deterioration.
- Open Access
- 21 July 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-10
Predictability of kinetic estimated glomerular filtration rate for acute kidney injury in patients undergoing coronary artery bypass surgery
Acute kidney injury (AKI) is a serious complication of coronary artery bypass grafting (CABG). This study aimed to assess the efficacy of kinetic estimated glomerular filtration rate (KeGFR) in predicting AKI in patients undergoing CABG. Additionally, we sought to identify potential factors contributing to the occurrence of AKI. This retrospective cohort study was conducted at Shahid Chamran Specialty Heart Hospital in Isfahan, Iran, among patients undergoing CABG between November 2018 and May 2021. The baseline eGFR of the patients was calculated using the Modification of Diet in Renal Disease (MDRD) formula. Postoperatively, renal function was assessed using the KeGFR equation. The percentage decrease in KeGFR after surgery compared to baseline eGFR was utilized to evaluate its predictive ability for AKI incidence during hospitalization. According to KDIGO criteria, participants were divided into AKI and non-AKI groups. Among 558 included individuals (81.2% male), 186 patients (33.3%) were diagnosed with AKI during hospitalization. Patients with AKI were older and had more comorbidities like hypertension, heart failure, and anemia compared to those without AKI. Additionally, AKI cases exhibited higher rates of blood product transfusions, longer intubation periods, and extended intensive care unit (ICU) stays. The percentage decrease in KeGFR from baseline demonstrated acceptable accuracy in predicting AKI cases (AUC (95%CI): 0.808 (0.753 to 0.864)). Risk factors for AKI in our population included age over 65, smoking, and prolonged intubation time. We found that patients with higher values of neutrophil-lymphocyte-platelet ratio (NLPR) had an increased risk of developing AKI compared to those with lower values (OR: 1.74; 95%CI: 1.07 to 2.83). KeGFR demonstrated desirable predictive accuracy for AKI incidence following CABG. Meanwhile, NLPR emerged as a new clinically useful biomarker for monitoring renal function post-CABG. Further prospective investigations are recommended in different settings and other cardiac operations. Clinical trial number not applicable.
- 21 July 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-10
Open AccessPredictability of kinetic estimated glomerular filtration rate for acute kidney injury in patients undergoing coronary artery bypass surgery
Acute kidney injury (AKI) is a serious complication of coronary artery bypass grafting (CABG). This study aimed to assess the efficacy of kinetic estimated glomerular filtration rate (KeGFR) in predicting AKI in patients undergoing CABG. Additionally, we sought to identify potential factors contributing to the occurrence of AKI. This retrospective cohort study was conducted at Shahid Chamran Specialty Heart Hospital in Isfahan, Iran, among patients undergoing CABG between November 2018 and May 2021. The baseline eGFR of the patients was calculated using the Modification of Diet in Renal Disease (MDRD) formula. Postoperatively, renal function was assessed using the KeGFR equation. The percentage decrease in KeGFR after surgery compared to baseline eGFR was utilized to evaluate its predictive ability for AKI incidence during hospitalization. According to KDIGO criteria, participants were divided into AKI and non-AKI groups. Among 558 included individuals (81.2% male), 186 patients (33.3%) were diagnosed with AKI during hospitalization. Patients with AKI were older and had more comorbidities like hypertension, heart failure, and anemia compared to those without AKI. Additionally, AKI cases exhibited higher rates of blood product transfusions, longer intubation periods, and extended intensive care unit (ICU) stays. The percentage decrease in KeGFR from baseline demonstrated acceptable accuracy in predicting AKI cases (AUC (95%CI): 0.808 (0.753 to 0.864)). Risk factors for AKI in our population included age over 65, smoking, and prolonged intubation time. We found that patients with higher values of neutrophil-lymphocyte-platelet ratio (NLPR) had an increased risk of developing AKI compared to those with lower values (OR: 1.74; 95%CI: 1.07 to 2.83). KeGFR demonstrated desirable predictive accuracy for AKI incidence following CABG. Meanwhile, NLPR emerged as a new clinically useful biomarker for monitoring renal function post-CABG. Further prospective investigations are recommended in different settings and other cardiac operations. Clinical trial number not applicable.
- Open Access
- 25 October 2023
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 81, 127331
Dynamic changes of serum trace elements following cardiac surgery: A systematic review and meta-analysis
- 25 October 2023
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 81, 127331
Open AccessDynamic changes of serum trace elements following cardiac surgery: A systematic review and meta-analysis
- Open Access
- 10 March 2021
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2021, 1-6
Rhabdomyolysis plus Hypocalcemia and Diabetic Ketoacidosis as Concurrent Rare COVID-19 Manifestations
Background. Common manifestations of coronavirus disease 2019 (COVID-19) from its initial official introduction are mostly related to the respiratory system. However, other rarer presentations are reported nowadays. Case Presentations. We reported three cases of COVID-19-infected patients with rhabdomyolysis as well as two other rarer simultaneous signs, including hypocalcemia (Case 1) and diabetic ketoacidosis (DKA) (Case 2). Conclusion. Despite the fact that rhabdomyolysis is an infrequent manifestation of COVID-19, high clinical suspicion is required for proper diagnosis and management of this disease as well as other concurrent rarer presentations, including hypocalcemia and DKA for the prevention of further complications.
- 10 March 2021
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2021, 1-6
Open AccessRhabdomyolysis plus Hypocalcemia and Diabetic Ketoacidosis as Concurrent Rare COVID-19 Manifestations
Background. Common manifestations of coronavirus disease 2019 (COVID-19) from its initial official introduction are mostly related to the respiratory system. However, other rarer presentations are reported nowadays. Case Presentations. We reported three cases of COVID-19-infected patients with rhabdomyolysis as well as two other rarer simultaneous signs, including hypocalcemia (Case 1) and diabetic ketoacidosis (DKA) (Case 2). Conclusion. Despite the fact that rhabdomyolysis is an infrequent manifestation of COVID-19, high clinical suspicion is required for proper diagnosis and management of this disease as well as other concurrent rarer presentations, including hypocalcemia and DKA for the prevention of further complications.
- Open Access
- 1 January 2020
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2020 (1)
Polyserositis: An Extremely Rare Life‐Threatening Manifestation of Pheochromocytoma
The pericardium is an uncommon site for manifestation of pheochromocytoma. Herein, the case of a 57‐year‐old man with cardiac tamponade is presented. Pericardiocentesis was performed, and the vital signs were stabilized afterwards. An abdominal computed tomography (CT) scan illustrated a nonhomogeneous right adrenal mass suspicious of pheochromocytoma, planned for right adrenalectomy. He recovered well after surgery, and his subsequent follow‐ups did not reveal any complications.
- 1 January 2020
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2020 (1)
Open AccessPolyserositis: An Extremely Rare Life‐Threatening Manifestation of Pheochromocytoma
The pericardium is an uncommon site for manifestation of pheochromocytoma. Herein, the case of a 57‐year‐old man with cardiac tamponade is presented. Pericardiocentesis was performed, and the vital signs were stabilized afterwards. An abdominal computed tomography (CT) scan illustrated a nonhomogeneous right adrenal mass suspicious of pheochromocytoma, planned for right adrenalectomy. He recovered well after surgery, and his subsequent follow‐ups did not reveal any complications.